Tom leads ATV’s efforts in Healthcare technology.  He is currently pursing investment opportunities based on disruptive technologies that will significantly reduce costs and improve efficiency in how healthcare is delivered or wellness is improved and maintained. He works closely with the teams and represents ATV on the boards of several portfolio companies including Aperio, Valeritas, PolyRemedy, Gynesonics, and Zeltiq Aesthetics.  He also previously led the investment in Helixis which was acquired by Illumina (ILMN).

Prior to joining ATV, Tom had significant operating experience in the healthcare industry including various strategy,  business development, sales, and marketing roles at leading technology companies. Most recently he served as VP of corporate strategy and business development at McKesson Corporation, one of the primary players in the healthcare IT and services industry. Prior to McKesson, he was one of the early team members and managed sales and healthcare strategy for FitLinxx, a venture-backed startup that pioneered the fitness and activity monitoring market including the technology behind the Nike+ system.  Before that Tom was a Product Manager at Genentech and was responsible for the successful Nutropin™, Nutropin AQ™ and Pulmozyme™ franchises and he started his career as a consultant with The Wilkerson Group.

Tom holds an M.B.A. from the Wharton School, a B.A. from the University of Pennsylvania and was an All American rugby player. He also sheepishly admits he was once the New Hampshire State high school math champion.

Email: trodgers@atvcapital.com

Representative Investments

Healthcare
Aperio
Gynesonics
PolyRemedy
Valeritas
Helixis (acquired by Illumina)
Zeltiq Aesthetics

Cleantech
AltaRock
Solar Junction

Tom is a charter member of HealthTech Capital (www.healthtechcapital.com) and a mentor for BluePrint Health (www.blueprinthealth.org).